Comments on "Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population"

被引:1
|
作者
Gesteira Ponce, Alejandro [1 ]
机构
[1] Fdn Publ Galega Med Xenom SERGAS, Santiago De Compostela, Spain
关键词
COPY NUMBER;
D O I
10.1016/j.forsciint.2011.04.001
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
引用
收藏
页码:E7 / E8
页数:2
相关论文
共 50 条
  • [1] Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population
    Shi, Yan
    Xiang, Ping
    Li, Li
    Shen, Min
    FORENSIC SCIENCE INTERNATIONAL, 2011, 207 (1-3) : 183 - 187
  • [2] Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry
    Falzoi, Matteo
    Mossa, Alessandra
    Congeddu, Elena
    Saba, Luisella
    Pani, Luca
    PHARMACOGENOMICS, 2010, 11 (04) : 559 - 571
  • [3] SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS
    De Andres, F.
    Paulmichl, M.
    Llerena, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S61 - S61
  • [4] Suppression of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4/5 activity by a cocktail of inflammatory cytokines
    Foster, John
    Webber, Guy
    Ormsby, Terry
    Cheung, Yen-Ling
    Paul, Danny S.
    Webber, Colin
    Waring, Adrian
    DRUG METABOLISM REVIEWS, 2016, 48 : 89 - 89
  • [5] Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population
    Fernando de Andrés
    Catalina Altamirano-Tinoco
    Ronald Ramírez-Roa
    Carlos F Montes-Mondragón
    Pedro Dorado
    Eva M. Peñas-Lledó
    Adrián LLerena
    The Pharmacogenomics Journal, 2021, 21 : 140 - 151
  • [6] Effect of rivoceranib administered as 200 mg once daily on the pharmacokinetics of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 substrates
    Jang, Seong
    Wei, Xiaohui
    Meng, Xianzhang
    Reitano, Joseph
    Urity, Vinoo
    Park, Cheol Hee
    Strickland, Bill
    Lee, Grace
    Nguyen, David
    CANCER RESEARCH, 2024, 84 (07)
  • [7] CYP2D6, CYP2C19, CYP2C9 and CYP3A5 polymorphism in the Spanish population
    Llovo, R.
    Tudoli, I
    Carril, J. C.
    Fernandez-Novoa, L.
    Seoane, S.
    Cacabelos, R.
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2009, 2009, : 53 - 57
  • [8] Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population
    Jónrit Halling
    Maria S. Petersen
    Per Damkier
    Flemming Nielsen
    Philippe Grandjean
    Pál Weihe
    Stefan Lundgren
    Mia Sandberg Lundblad
    Kim Brøsen
    European Journal of Clinical Pharmacology, 2005, 61 : 491 - 497
  • [9] Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population
    Halling, J
    Petersen, M
    Damkier, P
    Nielsen, F
    Grandjean, P
    Weihe, P
    Lundgren, S
    Lundblad, M
    Brosen, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 491 - 497
  • [10] Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population
    Skadric, Ivan
    Stojkovic, Oliver
    INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2020, 134 (02) : 433 - 439